Prevalence of ergot derivatives in natural ryegrass pastures: Detection and pathogenicity in the horse

Theriogenology

Volumn 71, Issue 3, 2009, Pages 422-431

  Lezica, F P ^a   Filip, R ^b   Gorzalczany, S ^b   Ferraro, G ^b   de Erausquin, G A ^a,c   Rivas, C ^a   Ladaga, G J B ^a,d  

^a Grupo INCA   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Laboratorio Fundación   (Argentina)

Author keywords

Domperidone; Endophytes; Ergot alkaloids; Horse; Ryegrass toxicity

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; 1-(3-CHLOROPHENYL)PIPERAZINE; 2 [[(2 PYRIDYL)METHYL]SULFINYL]BENZIMIDAZOLE DERIVATIVE; BUSPIRONE; ERGOT ALKALOID; LANSOPRAZOLE; PIPERAZINE DERIVATIVE; RAIN;

ANIMAL; ANIMAL FOOD; ARTICLE; BIOASSAY; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; FEMALE; FOOD CONTAMINATION; FUNGUS; HORSE; HORSE DISEASE; ISOLATION AND PURIFICATION; LACTATION; LOLIUM; METABOLISM; SEASON; TIME;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ANIMAL FEED; ANIMALS; BIOLOGICAL ASSAY; BUSPIRONE; ERGOT ALKALOIDS; FEMALE; FOOD CONTAMINATION; FUNGI; HORSE DISEASES; HORSES; LACTATION; LOLIUM; PIPERAZINES; RAIN; SEASONS; TIME FACTORS;

EQUIDAE; LOLIUM; RATTUS;

EID: 58049191412     PISSN: 0093691X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.theriogenology.2008.08.010     Document Type: Article

References (38)

1. Bacon C.W., Lyons P.C., Porter J.K., and Robbins J.D. Ergot toxicity from endophyte-infected grasses: a review. Agron J 78 (1986) 106-116
2. Villahoz M., Moras E., Barboni A., Scharf V., Menchaca E., and de Guglielmone R. Reproductive problems of pregnant mares grazing fescue pastures in Argentina. Proceedings of the 10th International Cong Anim Reprod Artific Insem (1984) 100-101
3. Garret L.M., Heimann E.D., Wilson L.L., and Pfander W.H. Reproductive problems of pregnant mares grazing fescue pastures. J Anim Sci 50 (1980) 322
4. Monroe J.L., Cross D.L., Hutson L.W., Henricks D.M., Kennedy S.W., and Bridges W.C. Effect of selenium and endophyte-contaminated fescue on performance and reproduction in mares. J Equine Vet Sci 8 (1988) 148-153
5. Cross D.L. Fescue toxicosis in horses. In: Bacon C.W., and Hill N.S. (Eds). Neotyphodium grass interaction (1997), Plenum Press, New York 289-309
6. Cross D.L., Redmond J.R., and Strickland J.R. Equine fescue toxicosis: signs and solutions. J Anim Sci 73 (1995) 899-908
7. Blodgett D.J. Fescue toxicosis. Vet Clin North Am Equine Pract 17 (2001) 567-577
8. Silvestrini F., Liuzzi A., and Chiodini P.G. Effect of ergot alkaloids on growth hormone and prolactin secretion in humans. Pharmacology 16 (1978) 78S-87S
9. Odriosola E., Lopez T., Campero C., and Gimenez C. Rye grass staggers in heifers: a new mycotoxicosis in Argentina. Vet Hun Toxicol 35 (1993) 144-146
10. Miyazaki S., Fukumura M., Yoshioka M., and Yamanaka N. Detection of endophyte toxins in the imported perennial ryegrass straw. J Vet Med Sci 69 (2001) 1013-1015
11. Eerens J.P.J., Lucas R.J., Easton S., and White J.G.H. Influence of the endophyte (Neotyphodium lolii) on morphology, physiology, and alkaloid synthesis of perennial ryegrass during high temperature and water stress. I. Pasture production. NZ J Agric Res 41 (1988) 219-226
12. Miles C.O., Di Menna M.E., Jacobs S.W.L., Garthwaite I., Lane G.A., Prestidge R.A., et al. Endophytic fungi in indigenous Australasian grasses associated with toxicity to livestock. Appl Environ Microbiol 64 (1998) 601-606
13. Redmond L.M., Cross D.L., Strickland J.R., and Kennedy S.W. Efficacy of domperidone and sulpiride as treatments for fescue toxicosis in horses. Am J Vet Res 55 (1994) 722-729
14. Campbell C.E. Efficacy of three domperidone dose levels for treatment of fescue toxicosis in horses. J Anim Sci 74 Suppl. 1 (1996) 209-212
15. Maskall D.D., Zis A.P., Lam R.W., Clark C.M., and Kuan A.J. Prolactin response to buspirone challenge in the presence of dopaminergic blockade. Biol Psychiatry 38 (1995) 235-239
16. Meltzer H.Y., and Fleming R. Effect of buspirone on prolactin and growth hormone secretion in laboratory rodents and man. J Clin Psychiatry 43 (1982) 76-79
17. Meltzer H.Y., Gudelsky G.A., Lowy M.T., Nash J.F., and Koenig J.I. Neuroendocrine effects of buspirone: mediation by dopaminergic and serotonergic mechanisms. In: Tunnicliff G., Eison A.S., and Taylor O.P. (Eds). Buspirone: mechanisms and clinical aspects (1991), Academic Press, San Diego 177-192
18. Montani T., Distel R.A., and Busso C.A. Métodos de Estudio de la Vegetación. Guía de Trabajos Teórico-Prácticos de Ecología I. (1986), Universidad Nacional Del Sur. Bahia Blanca, Buenos Aires, Argentina
19. Michelon L.E., and Kelleher W.J. The spectrophotometric determination of ergot alkaloids. A modified procedure employing paradimethylaminobenzaldehyde. Lloydia 26 (1963) 192-201
20. Ferraro G.E., Debenedetti S.L., and Coussio D. Quantitative investigation of ergot growing in Argentina. J Pharm Pharmacol 28 (1976) 729-730
21. European Pharmacopoeia. Balogh scientific books. 5th edition (2006), European Pharmacopoeia Commission
22. Federation of Animal Science Societies. Guide for the care and use of agricultural animals in agricultural research and teaching (1999), FASS, Savoy, IL
23. Smith B.L., and Towers N.R. Mycotoxicoses of grazing animals in New Zealand. NZ Vet J 50 3 Suppl. (2002) 28-34
24. USP 28 Nf 23, United States Pharmacopeia; 1st edition 2004.
25. Hussein H.S., and Brasel J.M. Toxicity, metabolism, and impact of mycotoxins on humans and animals. Toxicology 167 (2001) 101-134
26. Rutschmann J., and Stadler P.A. Chemical background. In: Berde B., and Schild H.O. (Eds). Ergot alkaloids and related compounds (1978), Springer-Verlag, Berlin 29-83
27. Miles C.O., Wilkins A.L., Gallagher R.T., Hawkes A.D., Munday S.C., and Towers N.R. Synthesis and tremorgenicity of paxitriols and lolitriol: possible biosynthetic precursors of lolitrem B. J Agric Food Chem 40 (1992) 234-238
28. Kolb E. Recent knowledge on the mechanism of action and metabolism of mycotoxins. Z Gesamte Inn Med 39 (1984) 353-358
29. Yatham L.N., and Steiner M. Neuroendocrine probes of serotonergic function: a critical review. Life Sci 53 (1993) 447-463
30. Ben-Jonathan N., Arbogast L.A., and Hyde J.F. Neuroendocrine regulation of prolactin release. Prog Neurobiol 33 (1989) 399-447
31. Thompson F.N., Jones R.D., Stuedemann J.A., Mizinga K.M., and Smith C.K. Effect of metoclopramide on luteinizing hormone secretion in postpartum anestrous cows. Am J Vet Res 53 (1992) 727-730
32. Becker S.E., and Johnson A.L. Failure of metoclopramide-induced acute hyperprolactinemia to affect time of ovulation or spontaneous luteolysis in the cycling mare. J Equine Vet Sci 10 (1990) 275-279
33. Neuhauser H., Laakmann G., and Knossalla A. Neuroendocrine effects of buspirone. 16th CINP Congress. Psychopharmacology 96 Suppl. 1 (1988) 393
34. Traber J., and Glaser T. 5-HT1A receptor-related anxiolytics. Trends Pharmacol Sci 8 (1987) 432-437
35. McMillen B.A., Matthews R.T., Sanghera M.K., Shepard P.D., and German D.C. Dopamine receptor antagonism by the novel antianxiety drug, buspirone. J Neurosci 3 (1983) 733-738
36. Eison A.S., and Temple Jr. D.L. Buspirone: review of its pharmacology and current perspectives on its mechanism of action. Am J Med 80 (1986) 1-9
37. Graeff F.G. Serotonergic systems. Psychiatr Clin North Am 20 (1997) 723-739
38. Willins D.L., and Meltzer H.Y. Direct injection of 5-HT2A receptor agonists into the medial prefrontal cortex produces a head-twitch response in rats. J Pharmacol Exp Ther 282 (1997) 699-706